Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Aimmune Therapeutics revenue
Aimmune Therapeutics's revenue is $8.5 million.
What is Aimmune Therapeutics's revenue?
- Aimmune Therapeutics has 275 employees, and the revenue per employee ratio is $31,080.
- Aimmune Therapeutics peak revenue was $8.5M in 2024.
On this page
Zippi applies for you, and finds you a job.
Aimmune Therapeutics financing
Aimmune Therapeutics received early financing of $17.0M on 2013-11-21.
| Series | Round size | Date |
|---|---|---|
| Series A | $17M | 11/2013 |
| Series B | $80M | 03/2015 |
| Post Ipo Equity | $145M | 11/2016 |
| Post Ipo Equity | $98M | 11/2018 |
| Post Ipo Equity | $200M | 02/2020 |
Aimmune Therapeutics investors
| Investors | Security type |
|---|---|
| Longitude Capital | Series A |
| Adage Capital Management | Series B |
| Longitude Capital | Series B |
| Foresite Capital | Series B |
| RA Capital Management | Series B |
| FMR Co. | Series B |
| Aisling Capital | Series B |
| Nestlé Health Science SA | Post Ipo Equity |
| Nestlé Health Science SA | Post Ipo Equity |
| Nestlé Health Science SA | Post Ipo Equity |
Search for jobs
Aimmune Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Aimmune Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aimmune Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Aimmune Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aimmune Therapeutics. The data presented on this page does not represent the view of Aimmune Therapeutics and its employees or that of Zippia.
Aimmune Therapeutics may also be known as or be related to AIMMUNE THERAPEUTICS INC., Aimmune Therapeutics, Aimmune Therapeutics Inc, Aimmune Therapeutics, Inc. and Aimmune Therapeutics, Inc.,.